Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Psyched Wellness Ltd PSYCF


Primary Symbol: C.PSYC

Psyched Wellness Ltd. is a Canada-based health supplements company. The Company is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company creates organic, natural, and lab-tested mushroom products to promote health and wellness of people globally. The Company is in the process of developing a line of Amanita muscaria-derived water-based... see more

Recent & Breaking News (CSE:PSYC)

Psyched Wellness (CSE:PSYC) initiates a clinical sleep study

John Ballem  September 21, 2021

Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1

Newsfile September 21, 2021

Psyched Wellness Announces Participation in the H.C. Wainwright 23rd Annual Global Investment Conference

Newsfile September 10, 2021

Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1

Newsfile September 8, 2021

CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market

Newsfile August 17, 2021

Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its Work on the AME-1

Newsfile August 17, 2021

BTV Examines the Rapidly Expanding Psychedelics Market

Newsfile August 17, 2021

Psyched Wellness (CSE:PSYC) partners with CannaLabs to begin stability tests on AME-1

John Ballem  July 26, 2021

Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1

Newsfile July 26, 2021

Psyched Wellness Announces Filing of Amended and Restated MD&A

Newsfile July 22, 2021

Psyched Wellness Successfully Completes Its Largest Extraction and Shipment of AME-1 to Asia

Newsfile July 22, 2021

Amanda Galbraith, Principal at Navigator Joins the Board of Psyched Wellness

Newsfile July 7, 2021

Psyched Wellness (CSE:PSYC) receives positive results from preclinical study

Trevor Abes  July 6, 2021

Psyched Wellness Receives Positive Results from It's 14-Day Oral Toxicity Preclinical Study

Newsfile July 6, 2021

Psyched Wellness (CSE:PSYC) welcomes Matthew Singh as CPG and branding consultant

John Ballem  June 30, 2021

Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant

Newsfile June 30, 2021

Psyched Wellness (CSE:PSYC) commences next pre-clinical study on AME-1

John Ballem  June 28, 2021

Psyched Wellness Commences Next Pre-Clinical Study on AME-1

Newsfile June 28, 2021

Ketamine One Highlights Psychedelic Research and Announces New Clinical Trial

GlobeNewswire June 17, 2021

Psyched Wellness (CSE:PSYC) to present at the H.C. Wainwright Conference

John Ballem  June 11, 2021